Serum S-100 protein, relationship to clinical outcome in acute stroke.
about
Controversial significance of early S100B levels after cardiac surgeryThe S100B protein in biological fluids: more than a lifelong biomarker of brain distress.Primary study for the therapeutic dose and time window of picroside II in treating cerebral ischemic injury in ratsDetermining the Feasibility of Ambulance-Based Randomised Controlled Trials in Patients with Ultra-Acute Stroke: Study Protocol for the "Rapid Intervention with GTN in Hypertensive Stroke Trial" (RIGHT, ISRCTN66434824)Reliability of S100B in predicting severity of central nervous system injury.S100 as a marker of acute brain ischemia: a systematic review.Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.Sensitization and tolerization to brain antigens in stroke.S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.Evolving role of biomarkers in acute cerebrovascular disease.Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke.Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections.Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke.Serum S-100beta protein is a potential biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis.S100b protein levels in subretinal fluid in rhegmatogenous retinal detachment.
P2860
Q24804075-FF9BADA6-EE0B-4CC0-B3B6-080AFA5A5C1EQ34238722-9393BA49-88D3-43B7-B72A-13AA0B21FE2DQ35865923-CFD7F15E-185F-4BB3-9ED8-9C8CAB8D9F6DQ36344183-B401027E-A6B4-425B-B1E4-9502605D7CEDQ36830747-01A22063-6A88-4841-A56E-EC44DCC0B06FQ36984953-A5475187-962F-4E75-BC1F-D61966CE8669Q37158146-E6044244-F23F-46B4-866B-209DF8570892Q37244830-ED7EC493-67E9-4F78-A93F-B7149ABC865FQ37318243-D8DB91E2-0E55-4ACB-8563-97D9272A1A0EQ37997374-70D323C9-5E8C-4B1A-BAA2-E0E0BCFF1011Q38649591-6E5F7D54-DBC1-4A92-9FCA-44D5E47E9B31Q48417608-1A5DFCDF-F489-40FB-9FC8-C99029501E8AQ48735500-58F8FE87-DD13-4A46-904E-FDC5513A4B89Q48925554-DD43037B-1CFA-41A4-8FAC-D4A717D5B885Q49131289-752AD0FF-F73F-4764-898B-BF0AC436908EQ51333966-E3102CBE-9680-4F4C-88E4-97CDC38B65A4
P2860
Serum S-100 protein, relationship to clinical outcome in acute stroke.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@en
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@nl
type
label
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@en
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@nl
prefLabel
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@en
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@nl
P2093
P1476
Serum S-100 protein, relationship to clinical outcome in acute stroke.
@en
P2093
H D Abraha
J Garthwaite
R A Sherwood
R J Butterworth
W S Wassif
P304
P356
10.1177/000456329703400405
P478
34 ( Pt 4)
P577
1997-07-01T00:00:00Z